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The Role of Pedometers in the Assessment of Intermittent Claudication
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Objectives: to evaluate the role of pedometers in the assessment of patients with intermittent claudication by comparing
them with treadmill testing, post-exercise ankle brachial pressure index (ABPI) and physical function questionnaires.
Patients and methods: fifty patients with intermittent claudication were prospectively assessed by treadmill examination
measuring maximum walking distance (MWD) and post-exercise ABPI. Three physical function questionnaires: (1)
Medical Outcome Study Short Form-36 (MOS SF-36), Physical Function (PF). (2) MOS SF-36 Role limitation due to
Physical Problems (RP). (3) Walking Impairment Questionnaire (WIQ) were completed. Pedometers were used for one
week and the daily average number of steps taken by each patient recorded. Pedometers scores were compared with MWD,
post-exercise ABPI and physical function questionnaires scores using Spearman correlation test.
Results: pedometers estimation of daily physical activity moderately correlated with MWD (Rho=0.35, p=0.01), post-
exercise ABPI (Rho=0.35, p=0.01), MOS-SF 36 PF (Rho=0.31, p=0.02), MOS-SF RP (Rho=0.28, p=0.05) and
with WIQ (Rho=0.42, p=0.003).
Conclusions: they moderately correlate with treadmill testing, post-exercise ABPI, and with physical function ques-
tionnaires. Pedometers may provide a simple and cheap alternative for the assessment of physical and functional disability
in intermittent claudication.
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Introduction can be self-administered in a primary care setting.
Pedometers have been found to be accurate and re-
Intermittent claudication is a common problem in liable in the assessment of physical activity in both
western communities and is associated with both phys-
ical and functional disability, affecting the social and
occupational activities of the patients.1,2
The evaluation of the severity of intermittent clau-
dication requires an assessment of both physical and
functional impairments. Treadmill testing and post-
exercise ankle brachial pressure index (ABPI) together
with patient questionnaires such as the Medical Out-
come Study Short Form-36 (MOS SF-36), Physical
Function (PF), MOS SF-36 Role limitation due to Phys-
ical Problems (RP) domains and the Walking Im-
pairment Questionnaire (WIQ) have all been validated
and are used in the assessment of intermittent clau-
dication.3–8
Modern digital pedometers are small devices worn
inconspicuously on the belt line (Fig. 1). They are
designed to display an output proportional to the
number of footsteps and the distance walked by an
individual. Pedometers are cheap, easy to use and
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Hospital, Combe Park, Bath, BA1 3NG, U.K. Fig. 1. Sportline 345 pedometer.
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Table 1. Patients characteristics (n=50).healthy volunteers and patients with peripheral ar-
terial occlusive disease (PAOD).9–11 However, they have Age median (IQ) years 67 (62–73)
Gender (males) 39 (78%)never been correlated with the traditional methods of
Diabetics 9 (18%)claudication assessment.
Smokers 22 (44%)The aim of this study is to assess the usefulness of Hypertensive 33 (66%)
Hyperlipidaemics 22 (44%)pedometers in the assessment of intermittent clau-
dication by correlating pedometer readings with phys-
IQR (interquartile range).ical testing (MWD and post-exercise ABPI) and
functional testing (physical function questionnaires). Table 2. Variable median scores.
MWD (meters) 175 (107–250)
Post-exercise ABPI 0.29 (0.00–0.47)
MOS SF-36 (PF) score 45 (35–70)Patients and Methods
MOS SF-36 (RP) score 25 (0–100)
WIQ score 0.31 (0.19–0.53)
Patients Pedometer average daily steps 5728 (4037–7956)
Values in parentheses are interquartile ranges.Fifty patients with at least 6 months history of stable
MWD (maximum walking distance), ABPI (ankle brachial pressure
intermittent claudication were recruited between Feb- index), MOS-SF-36 (Medical Outcome Study Short Form-36 Ques-
tionnaire), PF (physical function), RP (role limitation due to physicalruary 2000 and July 2000. All patients had post-exercise
problems), WIQ (Walking Impairment Questionnaire).ABPI of less than 0.9. Patients aged below 40 or above
80 years old and those with severe cardiopulmonary
(RF) and WIQ scores for each individual patient. Thedisease or a non-vascular walking disability were ex-
Spearman correlation test was used for statistical ana-cluded. Only patients with two maximum walking
lysis (StatsDirect, CamCode, U.K.). Statistical sig-distance (MWD) scores within 25% of each other after
nificance was taken at the 5% level.a repeat test within one week were included and the
average score was used.
Results
Methods
All patients complied with all aspects of the study.
Patients were assessed with a standard treadmill test. Patient characteristics and demographics are presented
All tests were performed with 12 degrees incline at a in Table 1.
graded speed of up to 3.5 Km/h under the supervision Data for MWD, post-exercise ABPI, physical func-
of a vascular technologist for MWD and post-exercise tion questionnaires scores and the median and in-
ABPI recording. Three physical function ques- terquartile range of pedometers average daily number
tionnaires were completed and the individual scores of steps are presented in Table 2.
calculated: Table 3 shows the results of Spearman correlation
test for pedometer readings against all other variables.(1) The Medical Outcomes Study Short form-36
Pedometers estimation of daily physical activity mod-(MOS SF-36) questionnaire MOS SF-36 [PF],
erately correlated with MWD (Rho=0.35, p=0.01),(2) The Medical Outcomes Study Short form-36
post-exercise ABPI (Rho=0.35, p=0.01), MOS-SF 36(MOS SF-36) questionnaire MOS SF-36 [RP] and
PF (Rho=0.31, p=0.02), MOS-SF RP (Rho=0.28, p=(3) The Walking Impairment Questionnaire (WIQ).
0.05) and with WIQ (Rho=0.42, p=0.003).
Patients were then instructed in the use of a pedometer Figure 2 shows an X-Y plot of the correlation be-
(sportline 345, Sportline, Campbell, CA, U.S.A.). Pe- tween pedometer scores and MWD scores.
dometers were worn for one week when the patient
was mobile. The daily average number of steps taken
was calculated for each patient.
Discussion
Treadmill testingStatistics
Patients’ estimation of their claudication distances isPedometers data were compared to MWD and post-
exercise ABPI data and MOS SF36 (PF), MOS SF-36 very subjective and in many cases unreliable. The
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Table 3. Spearman correlation. assessing the severity of PAOD and its progression
into critical ischaemia, does not reflect the degree ofPedometer
functional disability suffered by the patient in the
MWD community.12–14
Rho 0.35 A change in treadmill performance in response top 0.01
therapy is the most commonly used endpoint in clinicalPost-ABPI
claudication trials. The advantage of using the tread-Rho 0.35
p 0.01 mill test to evaluate claudication treatment is that it
SF-36 PF provides objective data. However, it is an expensive
Rho 0.31 method and does not directly assess patients per-
p 0.03
ception of functional impairment, or whether therapy
SF-36 RP has resulted in benefit. For future clinical trials ofRho 0.28
p 0.05 claudication therapy, it has been suggested that
laboratory assessments should serve only as secondaryWIQ
Rho 0.42 endpoints.14
p 0.003
Rho=Spearman correlation co-
efficient.
p=two sided. Physical function questionnaires
MWD (maximum walking distance),
ABPI (ankle brachial pressure index),
SF-36 (Medical Outcome Study Short The Medical Outcomes Study Short Form-36 (MOS
Form-36 Questionnaire), PF (physical SF-36) questionnaire evaluates physical function and
function), RP (role limitation due to
general health perceptions as well as limitations duephysical problems), and WIQ (Walk-
ing Impairment Questionnaire). to mental health, social function and vitality.4,5 The
physical function aspects examined in an earlier ver-
sion of this questionnaire improved with exercise train-development of valid instruments for assessing clau-
dication severity and the effects of treatment is im- ing therapy for claudication.6
The Walking Impairment Questionnaire (WIQ)portant for choosing the right treatment for the patient.
Treadmill testing alone is not sufficient and the results quantifies the patient’s walking capability in terms of
defined distances and speeds and rates the severityare not always reproducible. Constant-load treadmill
testing exhibit a learning curve and a coefficient of of claudication pain during usual walking activities.4
Changes in graded treadmill exercise performancevariation of up to 45% for MWD. Using graded tread-
mill testing, the within-subject coefficient of variation correlate with changes in questionnaire scores and the
questionnaire responses are stable when repeated overfor MWD is approximately 12% to 13%.3 Post-exercise
ABPI, although considered to be the gold standard for time in control patients.3 The WIQ has been used
Fig. 2. Spearman correlation between pedometer and MWD scores.
Eur J Vasc Endovasc Surg Vol 23, April 2002
M. K. Nasr et al.320
previously in the PAOD population to evaluate supervised time than treadmill testing and ques-
tionnaires and can be self-administered. Pedometerchanges in community-based walking ability in re-
sponse to exercise training and surgical interven- may also prove a useful tool for assessing claudication
in a primary care setting and provide a primary end-tions.7,8
point for the effects of different treatments on the
degree of physical disability suffered by claudicants.
We believe that the use of pedometers for assessingPedometers
claudication represent a useful tool that can be added
to the current methods of assessment.The accuracy of digital pedometers (Sportline 345) was
studied in 25 healthy volunteers. For brisk walking,
the accuracy averaged 96%, slow walking accuracy
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